Category Archives: Cancer and neoplasms

Yale Urology Research [Q3: July-September 2023]

The following is a comprehensive list of Yale Urology faculty publications for the 3rd quarter of calendar year 2023. The listing is separated into primary and secondary faculty sections, then in descending published date order. Listed items include cite details and portions of each abstract/summary. Primary Faculty Wang C, Meriggiola MC, Amory JK, Barratt CLR, […]

MPN-Related Fatigue Has a ‘Profound Effect’ on Patients’ Quality of Life

Patients with myeloproliferative neoplasms (MPNs) experience a number of symptoms—and fatigue is one of them, explains Patrick Buxton, RN, BSN. MPNs are types of blood cancer and occurs when there is an abnormal change in stem cells within the bone marrow, according to the Leukemia and Lymphoma Society. This abnormal change can lead to increased […]

Eccrine poroma with concurrent basal cell carcinoma

Department of Dermatology, Sinopharm Dongfeng General Hospital, Hubei University of Medicine, Shiyan, Hubei, People’s Republic of China Correspondence: Jiao Wei; Xiao Xiong, Department of Dermatology, Sinopharm Dongfeng General Hospital, Hubei University of Medicine, Shiyan, Hubei, 442008, People’s Republic of China, Tel +86 15872706796 ; +86 13636169342, Email [email protected]; [email protected] Abstract: Eccrine poroma (EP) is a […]

What to Know About Processed and Ultra-Processed Foods

Defining processed and ultra-processed foodsDispelling the myth around processed foodsNutritional content and impactUnderstanding food labelsThe role of processed and ultra-processed foods in modern dietsConclusionReferencesFurther reading Dietary choices significantly impact global health, contributing to approximately 11 million deaths through conditions like diabetes, cancer, and cardiovascular diseases. Image Credit: Phairoh chimmi/Shutterstock.com The American Institute for Cancer Research […]

Retrospective Analysis of Ocular Cancer in Saudi Arabia

Introduction Ocular oncology holds a distinctive role within the field of ophthalmology. Not only do these conditions pose a significant threat to vision, but they also carry the risk of potential eye loss, and some of them can even impact life expectancy.1 The development of specific tumor care procedures and the establishment of policies are […]

Widening area-based socioeconomic inequalities in cancer mortality in Germany between 2003 and 2019

Abstract Cancer mortality has declined in recent decades, but—due to a lack of national individual-level data—it remains unclear whether this applies equally to all socioeconomic groups in Germany. Using an area-based approach, this study investigated socioeconomic inequalities in cancer mortality and their secular trends on a German nationwide scale for the first time. Official cause-of-death […]

ESMO to Highlight Immunotherapy Advances, Cancer Detection and Prevention, and the Needs of Caregivers

Image credit: ESMO The latest data on drug regimens in a variety of cancers will take the stage at ESMO Congress 2023. In addition, the conference schedule is focusing on new technologies and access to treatments. This year, ESMO Congress 2023 will be held both virtually and in person in Madrid, Spain. The Congress will […]

Hydration and Movement Are Important for Patients With MPNs

Patients with myeloproliferative neoplasms (MPNs) — a group of blood cancers that causes the bone marrow to overproducer red or white blood cells or platelets and which includes polycythemia vera, essential thrombocythemia and myelofibrosis) — are at particular risk for thrombotic and cardiovascular events. “It’s really a problem for all patients with cancer because it does increase […]

SOPHiA GENETICS Enters New Collaboration with Memorial Sloan Kettering Cancer Center and AstraZeneca to Address Global Inequalities in Comprehensive Cancer Care

The three companies will collaborate to improve global access to advanced cancer testing and data, broadening access to cutting-edge science BOSTON, USA and ROLLE, Switzerland, October 18, 2023 / B3C newswire / — SOPHiA GENETICS (Nasdaq: SOPH), a category-defining software company and a global leader in data-driven medicine today announced a collaboration with Memorial Sloan […]